首站-论文投稿智能助手
典型文献
Seroprevalence of neutralizing antibodies against adenovirus type 26 and 35 in healthy populations from Guangdong and Shandong provinces,China
文献摘要:
Human adenoviruses type 26(HAdV26)and type 35(HAdV35)have increasingly become the choice of adenovirus vectors for vaccine application.However,the population pre-existing immunity to these two adenoviruses in China,which may reduce vaccine efficacy,remains largely unknown.Here,we established micro-neutralizing(MN)assays to investigate the seroprevalence of neutralizing antibodies(nAbs)against HAdV26 and HAdV35 in the general population of Guangdong and Shandong provinces,China.A total of 1184 serum samples were collected,47.0%and 15.8%of which showed HAdV26 and HAdV35 nAb activity,respectively.HAdV26-seropositive individuals tended to have more moderate nAbs titers(201-1000),while HAdV35-seropositive individuals appeared to have more low nAbs titers(72-200).The seropositive rates of HAdV26 and HAdV35 in individuals younger than 20 years old were very low.The seropositive rates of HAdV26 increased with age before 70 years old and decreased thereafter,while HAdV35 seropositive rates did not show similar characteristics.Notably,the seropositive rates and nAb levels of both HAdV26 and HAdV35 were higher in Guangdong Province than in Shandong Province,but did not exert significant differences between males and females.The seroprevalence between HAdV26 and HAdV35 showed little correlation,and no significant cross-neutralizing activity was detected.These results clarified the characteristics of the herd immunity against HAdV26 and HAdV35,and provided information for the rational development and application of HAdV26 and HAdV35 as vaccine vectors in China.
文献关键词:
作者姓名:
Haisu Yi;Qian Wang;Jiankai Deng;Hengchun Li;Yingkun Zhang;Zhilong Chen;Tianxin Ji;Wenming Liu;Xuehua Zheng;Qinghua Ma;Xinxin Sun;Yudi Zhang;Xuegao Yu;Mengzhang He;Ling Chen;Ying Feng
作者机构:
State Key Laboratory of Respiratory Disease,National Clinical Research Center for Respiratory Disease,Guangzhou Institute of Respiratory Health,The First Affiliated Hospital of Guangzhou Medical University,Guangzhou,510120,China;Department of Laboratory Medicine,The First Affiliated Hospital,Sun Yat-sen University,Guangzhou,510080,China;Center for Infection and Immunity,Guangzhou Institutes of Biomedicine and Health,Chinese Academy of Sciences,Guangzhou,510530,China;University of Chinese Academy of Science,Beijing,100049,China;Clinical Laboratory,Pingyi Hospital of Chinese Medicine,Linyi,273399,China;Xiamen Institutes of Respiratory Health,Xiamen,361013,China;Department of Respiratory and Critical Care Medicine,The Second Affiliated Hospital of Guangzhou Medical University,Guangzhou,510260,China;Guangzhou Laboratory&Bioland Laboratory,Guangzhou,510320,China
文献出处:
引用格式:
[1]Haisu Yi;Qian Wang;Jiankai Deng;Hengchun Li;Yingkun Zhang;Zhilong Chen;Tianxin Ji;Wenming Liu;Xuehua Zheng;Qinghua Ma;Xinxin Sun;Yudi Zhang;Xuegao Yu;Mengzhang He;Ling Chen;Ying Feng-.Seroprevalence of neutralizing antibodies against adenovirus type 26 and 35 in healthy populations from Guangdong and Shandong provinces,China)[J].中国病毒学,2022(05):716-723
A类:
adenoviruses,HAdV26,HAdV35,seroprevalence,nAbs
B类:
Seroprevalence,neutralizing,antibodies,against,type,healthy,populations,from,Guangdong,Shandong,provinces,China,Human,have,increasingly,become,choice,vectors,vaccine,application,However,existing,immunity,these,two,which,may,reduce,efficacy,remains,largely,unknown,Here,established,micro,MN,assays,investigate,general,total,serum,samples,were,collected,showed,activity,respectively,seropositive,individuals,tended,more,moderate,titers,while,appeared,low,rates,younger,than,years,old,very,increased,age,before,decreased,thereafter,did,not,similar,characteristics,Notably,levels,both,higher,Province,but,exert,significant,differences,between,females,little,correlation,cross,was,detected,These,results,clarified,herd,provided,information,rational,development
AB值:
0.386191
相似文献
Urinary bladder cancer as a late sequela of traumatic spinal cord injury
Ralf Böthig;Christian Tiburtius;Wolfgang Schöps;Michael Zellner;Oliver Balzer;Birgitt Kowald;Sven Hirschfeld;Roland Thietje;Aki Pietsch;Ines Kurze;Martin Forchert;Thura Kadhum;Klaus Golka-Department of Neuro-Urology,Centre for Spinal Cord Injuries,BG Klinikum Hamburg,21033 Hamburg,Germany;Urological Practice,53757 Sankt Augustin,Germany;Department of Urology and Neuro-Urology,Johannesbad Fachklinik,94072 Bad Füssing,Germany;Biomechanical Laboratory,Centre for Spinal Cord Injuries,BG Klinikum Hamburg,21033 Hamburg,Germany;Centre for Spinal Cord Injuries,BG Klinikum Hamburg,21033 Hamburg,Germany;Department of Sports and Rehabilitation Medicine,BG Klinikum Hamburg,21033 Hamburg,Germany;Department of Paraplegiology and Neuro-Urology,Centre for Spinal Cord Injuries,Zentralklinik Bad Berka,99437 Bad Berka,Germany;Staff Position Accident Insurance Law,Statutory Accident Insurance for Wood and Metal(BGHM),33602 Bielefeld,Germany;Department of Psychosomatic Rehabilitation,Mittelrheinklinik Fachklinik,56154 Boppard-Bad Salzig,Germany;Clinical Occupational Medicine,Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund(IfADo),44139 Dortmund,Germany
Development and evaluation of the screening performance of a low-cost high-risk screening strategy for breast cancer
Yubei Huang;Huan Wang;Zhangyan Lyu;Hongji Dai;Peifang Liu;Ying Zhu;Fengju Song;Kexin Chen-Department of Cancer Epidemiology and Biostatistics,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy of Tianjin,Tianjin's Clinical Research Center for Cancer,Key Laboratory of Cancer Molecular Epidemiology of Tianjin,Key Laboratory of Breast Cancer Prevention and Therapy,Ministry of Education,Tianjin 300060,China;Department of Breast Imaging,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy of Tianjin,Tianjin's Clinical Research Center for Cancer,Key Laboratory of Cancer Molecular Epidemiology of Tianjin,Key Laboratory of Breast Cancer Prevention and Therapy,Ministry of Education,Tianjin 300060,China
Risk of gestational diabetes recurrence and the development of type 2 diabetes among women with a history of gestational diabetes and risk factors: a study among 18 clinical centers in China
Wei Yumei;Juan Juan;Su Rina;Song Geng;Chen Xu;Shan Ruiqin;Li Ying;Cui Shihong;Fan Shangrong;Feng Ling;You Zishan;Meng Haixia;Cai Yan;Zhang Cuilin;Yang Huixia-Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China;Department of Obstetrics, Tianjin Central Obstetrics and Gynecology Hospital, Tianjin 300199, China;Department of Obstetrics, Jinan Maternal and Child Health Hospital, Jinan, Shandong 250000, China;Department of Obstetrics, Dalian Maternity Hospital, Dalian, Liaoning 116033, China;Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China;Department of Obstetrics, Shenzhen Peking University Hospital, Shenzhen, Guangdong 518036, China;Department of Obstetrics and Gynecology, Tongji Hospital Affiliated to Huazhong University of Science and Technology, Wuhan, Hubei 430030, China;Department of Obstetrics and Gynecology, Suzhou Jiulong Hospital Affiliated to Shanghai Jiaotong University, Suzhou, Jiangsu 320571, China;Department of Obstetrics, Affiliated Hospital of Inner Mongolia Medical University, Huhhot, Inner Mongolia 010050, China;Department of Obstetrics and Gynecology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China;Epidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20817, USA
Sex disparity of lung cancer risk in non-smokers: a multicenter population-based prospective study based on China National Lung Cancer Screening Program
Wu Zheng;Tan Fengwei;Yang Zhuoyu;Wang Fei;Cao Wei;Qin Chao;Dong Xuesi;Zheng Yadi;Luo Zilin;Zhao Liang;Yu Yiwen;Xu Yongjie;Ren Jiansong;Shi Jufang;Chen Hongda;Li Jiang;Tang Wei;Shen Sipeng;Wu Ning;Chen Wanqing;Li Ni;He Jie-Office of Cancer Screening, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;Key Laboratory of Cancer Data Science, Chinese Academy of Medical Sciences, Beijing 100021, China;Department of Thoracic Surgery, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;PET-CT Center, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China;Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu 211166, China;Department of Diagnostic Radiology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
Association of low cadmium and mercury exposure with chronic kidney disease among Chinese adults aged ≥80 years: A cross-sectional study
Wei Yuan;Lyu Yuebin;Cao Zhaojin;Zhao Feng;Liu Yingchun;Chen Chen;Li Chengcheng;Gu Heng;Lu Feng;Zhou Jinhui;Wu Bing;Liu Yang;Li Juan;Shi Xiaoming-China CDC Key Laboratory of Environment and Population Health, National Institute of Environmental Health, Chinese Center for Disease Control and Prevention, Beijing 100021, China;Department of Hygienic Inspection, School of Public Health, Jilin University, Changchun, Jilin 130021, China;Beijing Municipal Health Commission Information Center, Beijing Municipal Health Commission Policy Research Center, Beijing 100034, China;Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China;Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, Jilin 130021, China
A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice,rabbits and NHPs
Zezhong Liu;Jie Zhou;Wei Xu;Wei Deng;Yanqun Wang;Meiyu Wang;Qian Wang;Ming Hsieh;Jingming Dong;Xinling Wang;Weijin Huangei;Lixiao Xing;Miaoling He;Chunlin Tao;Youhua Xie;Yilong Zhang;Youchun Wang;Jincun Zhao;Zhenghong Yuan;Chuan Qin;Shibo Jiang;Lu Lu-Key Laboratory of Medical Molecular Virology(MOE/NHC/CAMS),School of Basic Medical Sciences;Shanghai Institute of Infectious Disease and Blosecurity;Biosafety Level 3 Laboratory,Shanghai Medical College,Shanghai Frontiers Science Center of Pathogenic Microbes and Infection,Fudan University,Shanghai,China;Key Laboratory of Human Disease Comparative Medicine,National Health Commission of the People's Republic of China;Beijing Key Laboratory for Animal Models of Emerging and Reemerging Infectious Diseases,Institute of Laboratory Animal Science,Chinese Academy of Medical Sciences and Comparative Medicine Center,Peking Union Medical College,Beijing,China;State Key Laboratory of Respiratory Disease,National Clinical Research Center for Respiratory Disease,Guangzhou Institute of Respiratory Health,the First Affiliated Hospital of Guangzhou Medical University,Guangzhou,Guangdong,China;Institute of Infectious Disease,Guangzhou Eighth People's Hospital of Guangzhou Medical University,Guangzhou,Guangdong,China;Guangzhou Laboratory,Bio-Island,Guangzhou,China;Graduate School of Peking Union Medical College,No.9 Dongdan Santiao,Dongcheng District,Beijing,China;Division of HIV/AIDS and Sex-transmitted Virus Vaccines,Institute for Biological Product Control,National Institutes for Food and Drug Control(NIFDC),No.31 Huatuo Street,Daxing District,Beijing,China;Fulgent Pharma LLC.,4978 Santa Anita Avenue,Temple City,CA,USA
Early assessment of the safety and immunogenicity of a third dose(booster)of COVID-19 immunization in Chinese adults
Yuntao Zhang;Yunkai Yang;Niu Qiao;Xuewei Wang;Ling Ding;Xiujuan Zhu;Yu Liang;Zibo Han;Feng Liu;Xinxin Zhang;Xiaoming Yang-China National Biotec Group Company Limited,Beijing 100024,China;Shanghai Institute of Hematology,State Key Laboratory of Medical Genomics,National Research Center for Translational Medicine at Shanghai,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Beijing Institute of Biological Products,China National Biotec Group Company Limited,Beijing 100176,China;National Vaccine and Serum Institute,China National Biotec Group Company Limited,Beijing 101111,China;Department of Infectious Diseases,Research Laboratory of Clinical Virology,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China
Seroprevalence of influenza viruses in Shandong,Northern China during the COVID-19 pandemic
Chuansong Quan;Zhenjie Zhang;Guoyong Ding;Fengwei Sun;Hengxia Zhao;Qinghua Liu;Chuanmin Ma;Jing Wang;Liang Wang;Wenbo Zhao;Jinjie He;Yu Wang;Qian He;Michael J.Carr;Dayan Wang;Qiang Xiao;Weifeng Shi-Key Laboratory of Etiology and Epidemiology of Emerging Infectious Diseases in Universities of Shandong,Shandong First Medical University&Shandong Academy of Medical Sciences,Taian 271000,China;School of Public Health,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250117,China;The Department of Infectious Disease,The Second Affiliated Hospital of Shandong First Medical University,Taian 271000,China;Clinical Laboratory,The Department of Clinical Laboratory,Boshan District Hospital,Zibo 255200,China;Clinical Laboratory,The Department of Clinical Laboratory,The Second Affiliated Hospital of Shandong First Medical University,Taian 271000,China;The Department of Cancer Center,Taian Tumor Prevention and Treatment Hospital,Taian 271000,China;National Virus Reference Laboratory,School of Medicine,University College Dublin,Dublin 4,Ireland;International Collaboration Unit,International Institute for Zoonosis Control,Hokkaido University,Sapporo,Hokkaido,001-0020,Japan;Chinese National Influenza Center,National Institute for Viral Disease Control and Prevention,Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases,Chinese Center for Disease Control and Prevention,Key Laboratory for Medical Virology,National Health and Family Planning Commission,Beijing 102206,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。